Navidea Biopharmaceuticals Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
1,130.60
6,274.80
13,249.30
4,971.60
1,810.40
1,169.40
Cost of Goods Sold (COGS) incl. D&A
737.00
2,074.10
2,226.20
563.60
258.20
247
Gross Income
393.60
4,200.80
11,023.10
4,408.00
1,552.20
922.30
SG&A Expense
38,831.90
31,182.80
28,273.60
14,556.70
14,324.20
10,669.60
EBIT
38,438.30
26,982.00
17,250.50
-
12,772.00
9,747.30
Unusual Expense
1,484.30
4,603.60
4,355.50
2,858.50
4,447.30
6,391.60
Non Operating Income/Expense
16.90
72.80
26.80
67.70
739.30
1.10
Interest Expense
2,778.80
3,706.20
6,873.70
5.00
159.00
161
Pretax Income
42,699.50
35,726.70
28,758.20
7,377.90
17,789.70
16,168.60
Income Tax
-
-
436.10
-
4,062.50
9.80
Consolidated Net Income
42,699.50
35,726.70
28,322.10
7,377.90
13,727.20
16,158.80
Net Income
42,699.50
35,726.70
28,321.30
7,377.20
13,727.00
16,158.40
Net Income After Extraordinaries
42,699.50
35,726.70
29,079.90
446.10
102,400.00
16,202.90
Net Income Available to Common
42,699.50
35,726.70
27,608.70
14,308.40
14,217.70
16,157
EPS (Basic)
0.35
0.24
0.18
0.09
0.45
1.89
Basic Shares Outstanding
121,809.00
148,748.40
151,180.20
155,422.40
161,592.60
8,526.80
EPS (Diluted)
0.35
0.24
0.18
0.09
0.46
1.89
Diluted Shares Outstanding
121,809.00
148,748.40
151,180.20
155,422.40
161,592.60
8,526.80
EBITDA
38,034.10
26,481.80
16,679.10
9,647.40
12,517.40
9,596.90
Non-Operating Interest Income
18.80
16.10
-
0.10
328.00
130.20
Minority Interest Expense
-
-
0.90
0.60
0.20
0.40
Equity in Affiliates (Pretax)
-
523.80
305.30
15.20
-
-
Preferred Dividends
-
-
46.00
-
-
-
About Navidea Biopharmaceuticals
View Profile
